My Health StudioThe My Heath Studio Gym in Thousand Oaks is designed and built specifically for people with MS. Visit myhealthstudio.com

The following studies are underway in the late stages of research. We're watching them closely.

MS

October 20, 2020
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis

https://www.sciencedaily.com/releases/2020/10/201020131338.htm 

December 20, 2020
Researchers have identified an immune cell in mice that promotes axon regeneration and neuronal survival and could potentially be harnessed as a treatment for brain, spinal cord, and optic nerve damage.

https://journals.lww.com/neurotodayonline/Fulltext/2020/12030/A_Newly_Identified_Immune_Cell_Promotes_Axon.2.aspx

January 19, 2021
Fatty acid may help combat multiple sclerosis

https://news.yale.edu/2021/01/19/fatty-acid-may-help-combat-multiple-sclerosis

Regrowing Myelin

Simple sugar possible therapy for repairing myelin in multiple sclerosis

https://www.sciencedaily.com/releases/2020/10/201007145416.htm

Mechanisms identified to restore myelin sheaths after injury or in multiple sclerosis 

https://www.sciencedaily.com/releases/2020/08/200824105529.htm

 

Pain

Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy (A peer-reviewed study)

https://www.dovepress.com/advances-with-long-non-coding-rnas-in-diabetic-peripheral-neuropathy-peer-reviewed-fulltext-article-DMSO

Kolon begins testing gene therapy for neuropathic pain in US

http://www.koreabiomed.com/news/articleView.html?idxno=8095

EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain

https://www.prnewswire.com/news-releases/eicosis-ec5026-granted-fast-track-designation-by-fda-for-neuropathic-pain-301037943.html

EC5026 just passed Phase 1a Clinical Trial, Nov 15, 2020:

https://www.prnewswire.com/news-releases/eicosis-successfully-completes-phase-1a-clinical-trial-of-ec5026-301174243.html